抑制mTOR通路可降低SLE患者单核细胞经STING途径产生的IFNα
该研究探讨SLE患者髓系细胞在cGAS-STING通路刺激下产生IFNα的能力,发现单核细胞、传统树突状细胞和浆细胞样树突状细胞均可产生IFNα,且产IFNα单核细胞频率与疾病活动度正相关;狼疮单核细胞STING表达及其与TBK1共定位增加,既往IFNα暴露增强单核细胞产IFNα能力;体外雷帕霉素抑制mTOR通路可下调增强的STING表达及下游分子并抑制IFNα产生。
要点
- 狼疮单核细胞经cGAS-STING通路激活后产生IFNα,其频率与SLE疾病活动度正相关。
- 狼疮单核细胞STING表达及其与TBK1共定位增加,既往IFNα暴露增强其产IFNα能力。
- 体外抑制mTOR通路可下调狼疮单核细胞增强的STING表达及下游分子并抑制IFNα产生。
核心结论
- 狼疮单核细胞因STING通路激活增强而产生过多IFNα,与SLE发病相关。
- 抑制mTOR通路可下调增强的STING表达及单核细胞后续IFNα产生。
研究设计与样本
- 研究比较SLE患者与健康对照外周血单个核细胞经2'3'c-GAMP刺激后的IFNα水平,采用细胞内细胞因子染色和流式细胞术检测。
- 通过流式细胞术或共聚焦显微镜检测STING表达及其与TBK1共定位,并体外观察IFNα暴露及雷帕霉素处理的影响。
主要发现
- cGAS-STING通路激活后,单核细胞、传统树突状细胞和浆细胞样树突状细胞均产生IFNα。
- 产IFNα单核细胞频率与SLE疾病活动度正相关。
- 狼疮单核细胞STING表达及其与TBK1共定位增加。
- 既往IFNα暴露增强单核细胞产IFNα能力。
- 抑制mTOR通路抑制单核细胞IFNα产生,并下调增强的STING表达及下游分子。
临床怎么用
- SLE中单核细胞经STING通路产生IFNα增多,提示该通路参与疾病活动。
- mTOR通路抑制可降低狼疮单核细胞增强的STING表达和IFNα产生,为靶向干预提供依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Increased IFNα is important in the pathogenesis of SLE. Plasmacytoid dendritic cells are considered the main producer of IFNα upon Toll-like receptor pathway activation. However, which cells produce IFNα following stimulation with cyclic GMP-AMP synthase (cGAS) and stimulator of IFN genes (STING) in SLE remains unknown. We investigated the IFNα producing capacity of myeloid cells under cGAS-STING pathway stimulation. METHODS: IFNα levels in peripheral blood mononuclear cells from SLE patients and healthy controls stimulated with 2'3'c-GAMP, a stimulator of cGAS-STING, were measured by intracellular cytokine staining and flow cytometry. STING expression and its co-localization with TBK1 were examined by flow cytometry or confocal microscopy. The effects of in vitro exposure to IFNα on IFNα production and STING expression, and in vitro rapamycin treatment on IFNα production and STING, pTBK1 and IRF3 expression were examined. RESULTS: IFNα was produced by monocytes, conventional dendritic cells and plasmacytoid dendritic cells upon cGAS-STING pathway activation. The frequency of IFNα-producing monocytes positively correlated with SLE disease activity. STING expression and its co-localization with TBK1 were increased in lupus monocytes. Prior exposure to IFNα enhanced the IFNα-producing capacity of monocytes. Inhibition of the mechanistic target of the rapamycin (mTOR) pathway suppressed IFNα production from monocytes and downregulated enhanced STING expression and its downstream molecules. CONCLUSION: Enhanced IFNα from lupus monocytes induced by augmented STING pathway activation is associated with SLE pathogenesis. Suppression of the mTOR pathway downregulated the enhanced STING expression and the subsequent IFNα production by monocytes.
引用
- Murayama G, Chiba A, Kuga T, et al. Inhibition of mTOR suppresses IFNα production and the STING pathway in monocytes from systemic lupus erythematosus patients. Rheumatology (Oxford). 2020. PMID: 32160289. doi:10.1093/rheumatology/keaa060
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。